Holtzman and Another v Sign and Seal Trading 32 (Pty) Limited and Others (9179/2017) [2022] ZAGPPHC 725 (26 September 2022)

Holtzman and Another v Sign and Seal Trading 32 (Pty) Limited and Others (9179/2017) [2022] ZAGPPHC 725 (26 September 2022)

The court found that while the existence of a loan agreement between Tara Developers (Pty) Ltd and the first defendant was established, the defendants failed to discharge the onus of proving the quantum of the loan account. The evidence presented, including financial statements and witness testimony, was insufficient and lacked direct corroboration, particularly in the absence of records from Blend Property Management, which managed the first defendant's finances. The auditors' disclaimers further diminished the probative value of the financial statements. Consequently, the court declared that the plaintiffs are entitled to 37.5% of the net proceeds held in trust after payment of all...

Citation
[2022] ZAGPPHC 725
Parties
Plaintiff: Zelda Lynn Holtzman; Plaintiff: The Executor in the Estate of the Late Alan Dunne N.O.; Defendant: Sign and Seal Trading 32 (Pty) Limited; Defendant: Bullet Proof Investments (Pty) Limited; Defendant: Into SA Tshwane (Pty) Limited; Defendant: Ralph Michael Ertner
Court
North Gauteng High Court, Pretoria
Jurisdiction
South Africa
Judgment Date
26 September 2022
Case Number
9179/2017
Procedural Posture
Civil Action / Trial Judgment
Outcome
Plaintiffs' claim granted. Defendants failed to prove the quantum of the alleged loan account. Plaintiffs entitled to 37.5% of net proceeds after SARS liabilities.
Judges
Bester
Legal Topics
Shareholder Entitlement, Distribution of Proceeds, Company Liabilities, Dividend Withholding Tax, Onus of Proof, Trust Account Protection

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 3 Party arguments 2 Amounts and remedies 3
Sign in to unlock

Parties

Zelda Lynn Holtzman

Plaintiff

The Executor in the Estate of the Late Alan Dunne N.O.

Plaintiff

Sign and Seal Trading 32 (Pty) Limited

Defendant

Bullet Proof Investments (Pty) Limited

Defendant

Into SA Tshwane (Pty) Limited

Defendant

Ralph Michael Ertner

Defendant

Procedural Posture

Civil Action / Trial Judgment

  1. 1 Whether the plaintiffs are entitled to 37.5% of the net proceeds from the sale of the immovable property held in trust after payment of amounts due to SARS.
  2. 2 Whether the first defendant is indebted to Tara Developers (Pty) Ltd in the amount claimed as a loan account, thereby reducing the distributable proceeds to shareholders.
  3. 3 Whether the first and second defendants discharged the onus of proving the existence and quantum of the alleged loan account.

Ratio Decidendi

The court found that while the existence of a loan agreement between Tara Developers (Pty) Ltd and the first defendant was established, the defendants failed to discharge the onus of proving the quantum of the loan account. The evidence presented, including financial statements and witness testimony, was insufficient and lacked direct corroboration, particularly in the absence of records from Blend Property Management, which managed the first defendant's finances. The auditors' disclaimers further diminished the probative value of the financial statements. Consequently, the court declared that the plaintiffs are entitled to 37.5% of the net proceeds held in trust after payment of all...

Court Disposition

Plaintiffs' claim granted. Defendants failed to prove the quantum of the alleged loan account. Plaintiffs entitled to 37.5% of net proceeds after SARS liabilities.

Orders

  • It is declared that the plaintiffs are entitled to 37.5% of the net proceeds held in trust by attorneys Cliffe Dekker Hofmeyr after payment of all or any amounts due to SARS.
  • Payment of 37.5% of the net proceeds minus deduction of all amounts due to SARS is to be made to the plaintiffs within ten days of final determination of the liability to SARS.